| Homo sapiens |
A-375 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2020.112903 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
BXPC-3 |
IC50 |
30000.0 |
nM |
10.1021/acs.jmedchem.0c01897 |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
IC50 |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
Ki |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
CDK12/Cyclin K |
Activity |
nan |
None |
10.1016/j.ejmech.2021.114012 |
| Homo sapiens |
Cereblon/Aiolos |
Activity |
13.0 |
% |
10.1021/acsmedchemlett.1c00368 |
| Homo sapiens |
Cereblon/Aiolos |
Activity |
18.0 |
% |
10.1021/acs.jmedchem.9b01928 |
| Homo sapiens |
Cereblon/Aiolos |
Activity |
nan |
None |
10.1016/j.ejmech.2019.01.023 |
| Homo sapiens |
Cereblon/Aiolos |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01921 |
| Homo sapiens |
Cereblon/Aiolos |
EC50 |
22.0 |
nM |
10.1021/acs.jmedchem.6b01921 |
| Homo sapiens |
Cereblon/BCR/ABL |
Activity |
-1.82 |
% |
10.1016/j.ejmech.2022.114810 |
| Homo sapiens |
Cereblon/BCR/ABL |
DC50 |
10.0 |
uM |
10.1016/j.ejmech.2021.113645 |
| Homo sapiens |
Cereblon/Bromodomain-containing protein 4 |
Activity |
nan |
None |
10.1016/j.bmc.2019.115228 |
| Homo sapiens |
Cereblon/Casein kinase I alpha |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.9b00454 |
| Homo sapiens |
Cereblon/Focal adhesion kinase 1 |
Activity |
nan |
None |
10.1021/acsmedchemlett.9b00372 |
| Homo sapiens |
Cereblon/GSPT1 |
DC50 |
10.0 |
uM |
10.1039/d2md00347c |
| Homo sapiens |
Cereblon/GSPT1 |
Emax |
10.0 |
% |
10.1039/d2md00347c |
| Homo sapiens |
Cereblon/Histone deacetylase 6 |
Activity |
-2.0 |
% |
10.1021/acs.jmedchem.9b00516 |
| Homo sapiens |
Cereblon/Histone deacetylase 6 |
Activity |
22.1 |
% |
10.1021/acs.jmedchem.9b00516 |
| Homo sapiens |
Cereblon/Ikaros |
Activity |
13.0 |
% |
10.1021/acsmedchemlett.1c00368 |
| Homo sapiens |
Cereblon/Ikaros |
Activity |
nan |
None |
10.1016/j.ejmech.2019.01.023 |
| Homo sapiens |
Cereblon/Ikaros |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01921 |
| Homo sapiens |
Cereblon/Ikaros |
Activity |
nan |
None |
10.1039/C9MD00185A |
| Homo sapiens |
Cereblon/Ikaros |
DC50 |
26.7 |
nM |
10.1021/acsmedchemlett.1c00475 |
| Homo sapiens |
Cereblon/Ikaros |
DC50 |
50.0 |
nM |
10.1039/d2md00347c |
| Homo sapiens |
Cereblon/Ikaros |
EC50 |
24.0 |
nM |
10.1021/acs.jmedchem.6b01921 |
| Homo sapiens |
Cereblon/Ikaros |
Emax |
89.0 |
% |
10.1039/d2md00347c |
| Homo sapiens |
Cereblon/Ikaros |
fEC50 |
111.0 |
nM |
10.1021/acsmedchemlett.1c00475 |
| Homo sapiens |
Cereblon/Ikaros |
Ratio |
4.6 |
None |
10.1039/C9MD00185A |
| Homo sapiens |
Cereblon/Protein-tyrosine phosphatase 2C |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113341 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DNA-binding protein Ikaros |
Activity |
100.0 |
% |
10.1021/acs.jmedchem.1c00270 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
E3 ubiquitin-protein ligase ZFP91 |
DC50 |
0.42 |
uM |
10.1021/acs.jmedchem.0c01897 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c00270 |
| Homo sapiens |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A |
Activity |
nan |
None |
10.1021/acsmedchemlett.2c00223 |
| Homo sapiens |
Hematopoietic prostaglandin D synthase |
Activity |
nan |
None |
10.1021/acsmedchemlett.0c00605 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.62 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
31.88 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
IC50 |
25.0 |
nM |
10.1016/s0960-894x(99)00250-4 |
| Homo sapiens |
HUVEC |
Inhibition |
21.0 |
% |
10.1016/j.bmcl.2005.08.086 |
| Homo sapiens |
JeKo-1 |
IC50 |
2617.33 |
nM |
10.1016/j.ejmech.2022.114459 |
| Homo sapiens |
JeKo-1 |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2022.114459 |
| Homo sapiens |
K562 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2021.113645 |
| Homo sapiens |
K562 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2022.114810 |
| Homo sapiens |
KARPAS-299 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.1c00270 |
| Homo sapiens |
MCF7 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2021.114013 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2021.114013 |
| Homo sapiens |
MIA PaCa-2 |
IC50 |
30000.0 |
nM |
10.1021/acs.jmedchem.0c01897 |
| Homo sapiens |
MM1.S |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00516 |
| Homo sapiens |
MM1.S |
IC50 |
21.93 |
nM |
10.1016/j.ejmech.2022.114459 |
| Homo sapiens |
MM1.S |
IC50 |
837.8 |
nM |
10.1016/j.ejmech.2022.114459 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
NCI-H929 |
CC50 |
35.0 |
nM |
10.1016/j.ejmech.2019.01.023 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
PBMC |
IC50 |
13.0 |
nM |
10.1016/j.bmcl.2012.10.071 |
| Homo sapiens |
PBMC |
IC50 |
13.0 |
nM |
10.1016/s0960-894x(99)00250-4 |
| Homo sapiens |
PBMC |
Inhibition |
95.0 |
% |
10.1016/s0960-894x(99)00250-4 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4 |
Inhibition |
50.0 |
% |
10.1016/s0960-894x(99)00250-4 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Programmed cell death protein 1/Programmed cell death 1 ligand 1 |
IC50 |
10.0 |
nM |
10.1016/j.ejmech.2020.112377 |
| Homo sapiens |
Protein cereblon |
Activity |
nan |
None |
10.1016/j.ejmech.2019.01.023 |
| Homo sapiens |
Protein cereblon |
IC50 |
739.0 |
nM |
10.1039/d2md00347c |
| Homo sapiens |
Protein cereblon |
IC50 |
1200.0 |
nM |
10.1021/acs.jmedchem.6b01921 |
| Homo sapiens |
Protein cereblon |
IC50 |
25800.0 |
nM |
10.1021/acsmedchemlett.0c00440 |
| Homo sapiens |
Protein cereblon |
Ki |
10000.0 |
nM |
10.1021/acsmedchemlett.0c00440 |
| Homo sapiens |
Protein cereblon/CDK9 |
Activity |
nan |
None |
10.1016/j.bmcl.2021.128061 |
| Homo sapiens |
Protein cereblon/Cyclin-dependent kinase 6 |
Activity |
nan |
None |
10.1016/j.bmcl.2019.03.035 |
| Homo sapiens |
Protein cereblon/Cyclin-dependent kinase 6 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00871 |
| Homo sapiens |
Protein cereblon/Cyclin-dependent kinase 7 |
Activity |
nan |
None |
10.1016/j.bmcl.2021.128061 |
| Homo sapiens |
Protein cereblon/DNA damage-binding protein 1 |
EC50 |
9.0 |
nM |
10.1021/acsmedchemlett.2c00223 |
| Homo sapiens |
Protein cereblon/Phosphodiesterase 6D |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00929 |
| Homo sapiens |
RPMI-8226 |
TGI |
46.0 |
% |
10.1021/acs.jmedchem.8b00961 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
THP-1 |
Activity |
7500.0 |
pg/ml |
10.1021/acs.jnatprod.7b01006 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
26653.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
VHL/CDK6 |
Activity |
76.0 |
% |
10.1021/acsmedchemlett.1c00368 |
| Homo sapiens |
VHL/CDK6 |
Activity |
nan |
None |
10.1021/acsmedchemlett.1c00368 |
| Homo sapiens |
VHL/Cyclin-dependent kinase 4 |
Activity |
70.0 |
% |
10.1021/acsmedchemlett.1c00368 |
| Homo sapiens |
VHL/Cyclin-dependent kinase 4 |
Activity |
nan |
None |
10.1021/acsmedchemlett.1c00368 |
| Homo sapiens |
Zinc finger protein Aiolos |
Activity |
100.0 |
% |
10.1021/acs.jmedchem.1c00270 |
| Magnetospirillum gryphiswaldense |
Cereblon isoform 4 |
Ki |
800.0 |
nM |
10.1021/acs.jmedchem.9b00454 |
| Mus musculus |
B16-F10 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2020.112903 |
| Mus musculus |
RAW264.7 |
Activity |
91.0 |
% |
10.1016/j.bmcl.2022.128972 |
| Mus musculus |
RAW264.7 |
Activity |
95.0 |
% |
10.1016/j.bmcl.2022.128972 |
| Rattus norvegicus |
Cereblon/Glycogen synthase kinase-3 beta |
Activity |
108.7 |
% |
10.1016/j.ejmech.2020.112949 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
5.5 |
% |
10.1021/jm0304820 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.3563 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.01474 |
None |
10.1101/2020.04.03.023846 |
| None |
ADMET |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.0c00793 |
| None |
ADMET |
Drug uptake |
nan |
None |
10.1016/j.bmc.2021.116331 |
| None |
ADMET |
F |
410.0 |
% |
10.1021/acsmedchemlett.1c00475 |
| None |
ADMET |
Fu |
0.9 |
None |
10.1021/acsmedchemlett.1c00475 |
| None |
ADMET |
IC50 |
230.0 |
nM |
10.1016/s0960-894x(03)00778-9 |
| None |
ADMET |
Kp |
4.5 |
None |
10.1021/acsmedchemlett.1c00475 |
| None |
ADMET |
Papp |
24.9 |
10^-6 cm/s |
10.1021/acsmedchemlett.1c00475 |
| None |
ADMET |
Ratio |
1.1 |
None |
10.1021/acsmedchemlett.1c00475 |
| None |
ADMET |
T1/2 |
2.333 |
hr |
10.1021/acs.jmedchem.0c00793 |
| None |
ADMET |
T1/2 |
2.65 |
hr |
10.1021/acsmedchemlett.1c00475 |
| None |
ADMET |
T1/2 |
3.1 |
hr |
10.1021/acsmedchemlett.1c00475 |
| None |
NON-PROTEIN TARGET |
IC50 |
30.0 |
nM |
10.1016/j.bmcl.2012.10.071 |
| None |
NON-PROTEIN TARGET |
Potency |
4727.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
5304.5 |
nM |
None |
| None |
No relevant target |
LogD |
0.787 |
None |
10.1021/acsmedchemlett.1c00475 |
| None |
No relevant target |
Log S |
-4.44 |
None |
10.1021/acs.jmedchem.2c00201 |
| None |
No relevant target |
Solubility |
78000.0 |
nM |
10.1021/acsmedchemlett.1c00475 |
| None |
T-cell |
EC50 |
8.0 |
nM |
10.1016/j.bmcl.2012.10.071 |
| None |
Unchecked |
Activity |
18.4 |
% |
10.1021/acs.jnatprod.0c00350 |
| None |
Unchecked |
Activity |
43.0 |
% |
10.1021/acs.jnatprod.0c00350 |
| None |
Unchecked |
Activity |
85.0 |
% |
10.1021/acs.jmedchem.6b01911 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2020.112800 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2021.114013 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c01206 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c01476 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01928 |
| None |
Unchecked |
EC50 |
27.0 |
nM |
10.1021/acs.jmedchem.6b01911 |
| None |
Unchecked |
EC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.6b01911 |
| None |
Unchecked |
GI |
nan |
None |
10.1021/acs.jnatprod.0c00350 |
| None |
Unchecked |
IC50 |
35.0 |
nM |
10.1016/j.ejmech.2021.114053 |
| None |
Unchecked |
IC50 |
1270.0 |
nM |
10.1016/j.bmcl.2007.01.088 |
| None |
Unchecked |
IC50 |
16518.0 |
nM |
10.1016/j.ejmech.2022.114459 |
| None |
Unchecked |
Kd |
157.0 |
nM |
10.1021/acs.jmedchem.9b00455 |
| None |
Unchecked |
TIME |
15.0 |
hr |
10.1016/j.ejmech.2021.113353 |
| None |
Unchecked |
TIME |
18.0 |
hr |
10.1016/j.ejmech.2021.113353 |